Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
This week saw Swiss CDMO, Lonza, announce a framework collaboration agreement with ALSA Ventures, a London based European biotech investment firm.
Archives for May 12, 2022
Bora Pharmaceuticals acquires CDMO assets from Eden Biologics
Taiwan based CDMO, Bora Pharmaceuticals, says the acquisition of CDMO assets from local player, Eden Biologics, will help it build a presence in large-molecule contract drug development and manufacturing.
What are the benefits of oral delivery of insulin and how can algae support candidate therapeutic proteins?
These are some of the questions we will be asking leading experts next week.